Taxane‐based chemohormonal therapy for metastatic hormone‐sensitive prostate cancer: a Cochrane Review

Taxane‐based chemohormonal therapy for metastatic hormone‐sensitive prostate cancer: a Cochrane Review

To provide a precis of the Cochrane Collaboration Review of taxane‐based chemohormonal therapy for metastatic hormone‐sensitive prostate cancer by Sathianathen NJ, Philippou YA, Kuntz GM et al. Cochrane Database of Systematic Reviews 2018, Issue 10. Art. No.: CD012816. https://doi.org/10.1002/146518...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BJU international 2019-09, Vol.124 (3), p.370-372
Hauptverfasser: Sathianathen, Niranjan J., Philippou, Yiannis A., Kuntz, Gretchen M., Konety, Badrinath R., Gupta, Shilpa, Lamb, Alastair D., Dahm, Philipp
Format: Artikel
Sprache:eng
Schlagworte:
Androgen Antagonists
Antineoplastic Combined Chemotherapy Protocols
chemotherapy
Humans
Male
Meta-analysis
Metastases
Metastasis
PCSM
Prostate cancer
ProstateCancer
Prostatic Neoplasms
systematic review
Taxoids
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To provide a precis of the Cochrane Collaboration Review of taxane‐based chemohormonal therapy for metastatic hormone‐sensitive prostate cancer by Sathianathen NJ, Philippou YA, Kuntz GM et al. Cochrane Database of Systematic Reviews 2018, Issue 10. Art. No.: CD012816. https://doi.org/10.1002/14651858.cd012816.pub2.
ISSN:1464-4096
1464-410X
DOI:10.1111/bju.14711